Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vioxx DTC Ads Do Not Undercut “Learned Intermediary” Defense, Merck Says

This article was originally published in The Pink Sheet Daily

Executive Summary

“We think our DTC ads are wholly consistent with the philosophy underlying the learned intermediary rule,” General Counsel Frazier says. Merck expects the first Vioxx personal injury trial will commence in the first half of 2005 in either Texas or Alabama.

You may also be interested in...



Failure To Implement DTC Guidelines Could Trigger DOJ Scrutiny – Asst. U.S. Attorney

Inappropriate direct-to-consumer advertising campaigns also expose companies to greater product liability, Assistant U.S. Attorney Meriwether says.

Failure To Implement DTC Guidelines Could Trigger DOJ Scrutiny – Asst. U.S. Attorney

Inappropriate direct-to-consumer advertising campaigns also expose companies to greater product liability, Assistant U.S. Attorney Meriwether says.

After Vioxx Withdrawal, First Thing For Merck Is Paying The Lawyers

Merck increases reserve for legal defense costs related to Vioxx by $604 mil., bringing the total to $675 mil.; the company has not yet established a reserve to cover potential liability. A hearing to consolidate pretrial motions to a single federal judge is scheduled for Jan. 27.

Related Content

Topics

UsernamePublicRestriction

Register

ID1132956

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel